This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

CTI BioPharma Corp.
$2.65 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 0
07/30/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
CTIC CTI BIOPHARMA CORP 2.66 399.03 n/m 34.96 3005.06
PRTA PROTHENA CORP PLC 18.48 492.58 n/m 32.74 4288.60
VNDA VANDA PHARMACEUTICALS INC 13.92 471.53 n/m 34.95 7.04
SPPI SPECTRUM PHARMACEUTICALS INC 7.10 465.63 n/m 155.93 -35.11
XOMA XOMA CORP 4.07 435.08 n/m 29.41 -11.88
AMAG AMAG PHARMACEUTICALS INC 18.50 405.43 n/m 83.81 -4.52
GERN GERON CORP 2.53 397.05 n/m 0.99 -55.32
SNSS SUNESIS PHARMACEUTICALS INC 6.38 384.18 n/m 7.96 38.63
DVAX DYNAVAX TECHNOLOGIES CORP 1.41 370.63 n/m 12.66 34.02
PGNX PROGENICS PHARMACEUTICAL INC 5.05 351.26 n/m 7.45 -46.97
DNDN DENDREON CORP 2.19 350.32 n/m 284.93 -8.40
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CTIC Ind Avg S&P 500
n/m 80.07 19.71

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs